Claire Mazumdar

Insider Reports History

Location
Boston, MA
Signature
/s/ Lara Meisner, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Claire Mazumdar:

Company Role Class Num Shares Value Price $ Report Date Ownership
Bicara Therapeutics Inc. Chief Executive Officer, Director Common Stock 339,392 $6,363,871 $18.75 06 Mar 2026 Direct
Relay Therapeutics, Inc. Director Stock Option (Right to Buy) 421,241 09 Jun 2025 Direct
Bicara Therapeutics Inc. Chief Executive Officer, Director Stock Option (Right to Buy) 227,873 06 Mar 2026 Direct

Insider Reports Filed by Claire Mazumdar

Symbol Company Period Transactions Value $ Form Type Role Filing Time
BCAX Bicara Therapeutics Inc. 04 Mar 2026 9 -$154,325 4 Chief Executive Officer, Director 06 Mar 2026, 19:27
BCAX Bicara Therapeutics Inc. 02 Feb 2026 1 $0 4 Chief Executive Officer, Director 04 Feb 2026, 16:37
BCAX Bicara Therapeutics Inc. 16 Dec 2025 2 +$160,884 4 Chief Executive Officer, Director 18 Dec 2025, 18:02
BCAX Bicara Therapeutics Inc. 24 Nov 2025 3 -$620,429 4 Chief Executive Officer, Director 25 Nov 2025, 18:40
BCAX Bicara Therapeutics Inc. 16 Oct 2025 3 -$362,415 4 Chief Executive Officer, Director 20 Oct 2025, 16:11
BCAX Bicara Therapeutics Inc. 13 Oct 2025 6 -$373,200 4 Chief Executive Officer, Director 15 Oct 2025, 18:00
RLAY Relay Therapeutics, Inc. 09 Jun 2025 1 $0 4 Director 11 Jun 2025, 16:16
RLAY Relay Therapeutics, Inc. 09 Jun 2025 0 $0 3 Director 11 Jun 2025, 16:15
BCAX Bicara Therapeutics Inc. 12 Sep 2024 0 $0 3 Chief Executive Officer, Director 12 Sep 2024, 21:09